CIK: 0001792126 · Show all filings
Period: Q4 2020 (← Previous) (Next →)
Filing Date: Feb 16, 2021
Total Value ($000): $1,166,506 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ALXO | ALX ONCOLOGY HLDGS INC | 3,156,981 | $272,132 | 23.3% | $39.31 | +53.0% | COM | 00166B105 |
| OLMA | OLEMA PHARMACEUTICALS INC | 3,743,875 | $180,006 | 15.4% | $46.89 | 0.0% | COM | 68062P106 |
| NKTX | NKARTA INC | 1,682,178 | $103,406 | 8.9% | $29.47 | +40.9% | COM | 65487U108 |
| — | FORMA THERAPEUTICS HLDGS INC | 1,400,000 | $48,860 | 4.2% | $44.61 | — | SHS | 34633R104 |
| TGTX | TG THERAPEUTICS INC | 850,000 | $44,217 | 3.8% | $19.16 | +76.3% | COM | 88322Q108 |
| DYN | DYNE THERAPEUTICS INC | 1,604,392 | $33,692 | 2.9% | $21.96 | -9.9% | COM | 26818M108 |
| — | ATHIRA PHARMA INC | 947,873 | $32,465 | 2.8% | $18.46 | — | COM | 04746L104 |
| KROS | KEROS THERAPEUTICS INC | 450,000 | $31,743 | 2.7% | $37.45 | +68.3% | COM | 492327101 |
| — | REPARE THERAPEUTICS INC | 676,894 | $23,217 | 2.0% | $30.54 | — | COM | 760273102 |
| — | KINNATE BIOPHARMA INC | 569,602 | $22,659 | 1.9% | $39.78 | — | COM | 49705R105 |
| COGT | COGENT BIOSCIENCES INC | 1,920,500 | $21,567 | 1.8% | $10.99 | 0.0% | COM | 19240Q201 |
| — | BIOXCEL THERAPEUTICS INC | 430,000 | $19,866 | 1.7% | $48.62 | — | COM | 09075P105 |
| APLS | APELLIS PHARMACEUTICALS INC | 300,000 | $17,160 | 1.5% | $42.30 | 0.0% | COM | 03753U106 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 200,000 | $17,142 | 1.5% | — | — | Call | G11196105 |
| RNAM | AVIDITY BIOSCIENCES INC | 671,454 | $17,136 | 1.5% | $28.83 | +1.1% | COM | 05370A108 |
| — | ALIGOS THERAPEUTICS INC | 606,548 | $16,771 | 1.4% | $27.65 | — | COM | 01626L105 |
| CCCC | C4 THERAPEUTICS INC | 477,928 | $15,834 | 1.4% | $29.00 | 0.0% | COM STK | 12529R107 |
| LRMR | LARIMAR THERAPEUTICS INC | 715,000 | $15,308 | 1.3% | $16.55 | +21.1% | COM | 517125100 |
| CMPS | COMPASS PATHWAYS PLC | 300,000 | $14,292 | 1.2% | $34.90 | — | SPONSORED ADS | 20451W101 |
| SPRY | SILVERBACK THERAPEUTICS INC | 300,000 | $13,902 | 1.2% | $33.40 | 0.0% | COM | 82835W108 |
| — | IGM BIOSCIENCES INC | 150,000 | $13,244 | 1.1% | $88.29 | — | COM | 449585108 |
| — | KARUNA THERAPEUTICS INC | 120,000 | $12,191 | 1.0% | $101.59 | — | COM | 48576A100 |
| ABCL | ABCELLERA BIOLOGICS INC | 300,000 | $12,072 | 1.0% | $45.73 | 0.0% | COM | 00288U106 |
| — | MIRATI THERAPEUTICS INC | 50,000 | $10,982 | 0.9% | $219.64 | — | COM | 60468T105 |
| — | CALLIDITAS THERAPEUTICS AB | 300,000 | $10,086 | 0.9% | $23.62 | — | SPONSERED ADS | 13124Q106 |
| — | CURIS INC | 1,200,000 | $9,828 | 0.8% | $8.19 | — | COM NEW | 231269200 |
| KALV | KALVISTA PHARMACEUTICALS INC | 490,000 | $9,305 | 0.8% | $13.16 | +30.3% | COM | 483497103 |
| — | MIRAGEN THERAPEUTICS INC | 550,000 | $9,048 | 0.8% | $16.45 | — | COM NEW | 60463E202 |
| — | PASSAGE BIO INC | 344,438 | $8,807 | 0.8% | $14.85 | — | COM | 702712100 |
| — | VINCERA PHARMA INC | 400,000 | $7,704 | 0.7% | $19.26 | — | UNIT 12/24/2025 | 92731L205 |
| NRIX | NURIX THERAPEUTICS INC | 230,297 | $7,572 | 0.6% | $25.20 | +31.5% | COM | 67080M103 |
| — | THERAPEUTICS ACQUISITION COR | 500,000 | $6,960 | 0.6% | $14.38 | — | COM CL A | 88339T103 |
| KYMR | KYMERA THERAPEUTICS INC | 110,920 | $6,877 | 0.6% | $30.53 | +59.8% | COM | 501575104 |
| — | ESSA PHARMA INC | 550,000 | $6,562 | 0.6% | $11.93 | — | COM NEW | 29668H708 |
| STTK | SHATTUCK LABS INC | 121,562 | $6,371 | 0.5% | $32.14 | 0.0% | COM | 82024L103 |
| PMVP | PMV PHARMACEUTICALS INC | 100,000 | $6,151 | 0.5% | $36.80 | +6.6% | COM | 69353Y103 |
| LUNG | PULMONX CORP | 75,000 | $5,177 | 0.4% | $48.97 | 0.0% | COM | 745848101 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 699,999 | $4,606 | 0.4% | $4.68 | 0.0% | COM NEW | 30233G209 |
| ANNX | ANNEXON INC | 159,622 | $3,995 | 0.3% | $23.46 | +9.7% | COM | 03589W102 |
| BDTX | BLACK DIAMOND THERAPEUTICS I | 123,465 | $3,957 | 0.3% | $30.22 | +8.7% | COM | 09203E105 |
| — | HEALTH SCIENCES ACQ CORP 2 | 300,000 | $3,843 | 0.3% | $11.00 | — | ORD SHS | G4411D109 |
| PCVX | VAXCYTE INC | 140,000 | $3,720 | 0.3% | $37.18 | 0.0% | COM | 92243G108 |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | 100,000 | $3,615 | 0.3% | $36.46 | +10.7% | COM | 413197104 |
| — | BRISTOL-MYERS SQUIBB CO | 5,050,000 | $3,485 | 0.3% | $3.09 | — | RIGHT 99/99/9999 | 110122157 |
| — | NOVUS THERAPEUTICS INC | 224,071 | $3,451 | 0.3% | $15.40 | — | COM | 67011N204 |
| — | ITEOS THERAPEUTICS INC | 100,000 | $3,382 | 0.3% | $24.67 | — | COM | 46565G104 |
| — | OUTSET MED INC | 50,000 | $2,842 | 0.2% | $50.00 | — | COM | 690145107 |
| — | PANACEA ACQUISITION CORP | 200,000 | $2,552 | 0.2% | $12.00 | — | UNIT 99/99/9999 | 698102209 |
| — | BCTG ACQUISITION CORP | 200,000 | $2,288 | 0.2% | $10.36 | — | COM | 05492W103 |
| MLTX | HELIX ACQUISITION CORP | 200,000 | $2,274 | 0.2% | $11.37 | — | COM CL A | G4444C102 |
| — | EARGO INC | 50,000 | $2,241 | 0.2% | $44.82 | — | COM | 270087109 |
| OPTEY | OPTHEA LTD | 160,000 | $1,794 | 0.2% | $11.21 | — | SPONSORED ADS | 68386J208 |
| PLRX | PLIANT THERAPEUTICS INC | 76,426 | $1,736 | 0.1% | $26.54 | -5.5% | COM | 729139105 |
| TVTX | TRAVERE THERAPEUTICS INC | 61,152 | $1,667 | 0.1% | $23.35 | 0.0% | COM | 89422G107 |
| — | CEREVEL THERAPEUTICS HLDNG I | 100,000 | $1,658 | 0.1% | $16.58 | — | COM | 15678U128 |
| — | APPLIED MOLECULAR TRANS INC | 42,847 | $1,318 | 0.1% | $30.76 | — | COM | 03824M109 |
| — | FS DEV CORP | 100,000 | $1,100 | 0.1% | $11.20 | — | COM CL A | 303020101 |
| — | GENERATION BIO CO | 17,000 | $482 | 0.0% | $28.35 | — | COM | 37148K100 |
| — | CEREVEL THERAPEUTICS HLDNG I | 33,333 | $188 | 0.0% | $5.64 | — | *W EXP 06/09/202 | 15678U102 |